

FDA Approves Tremfya (Guselkumab) for Adult Patients with Psoriatic Arthritis
Biosimilar Prescribing Habits in the VA & Academic Settings

Biosimilars Are Slowly Climbing Toward Acceptance in Rheumatology
U.S. Insurers Often Limit Biosimilar Coverage

Rheumatology Biologic Expertise Valued for COVID-19 Treatment Decisions

Rheumatoid Arthritis Therapy Update: What’s Changed & What’s the Same

Pediatric Cases Require Special Considerations & Aggressive Treatment Plans

Clinicians Discuss Current & Future Rheumatoid Arthritis Approaches

FDA Update: New Drug Approvals, New & Expanded Indications, & More
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 33
- Next Page »